Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 11.00B | 11.09B | 10.02B | 8.76B | 7.03B | 8.15B |
Gross Profit | 2.28B | 2.32B | 2.07B | 1.88B | 1.10B | 1.65B |
EBITDA | 1.16B | 1.50B | 1.49B | 1.07B | 654.30M | 823.00M |
Net Income | 501.41M | 632.25M | 538.06M | 163.77M | -109.55M | 70.00M |
Balance Sheet | ||||||
Total Assets | 15.95B | 16.11B | 15.41B | 14.37B | 14.15B | 13.10B |
Cash, Cash Equivalents and Short-Term Investments | 3.78B | 3.57B | 3.74B | 3.29B | 3.02B | 3.69M |
Total Debt | 1.30B | 1.76B | 2.32B | 2.43B | 2.57B | 1.40B |
Total Liabilities | 4.62B | 5.14B | 5.45B | 5.10B | 5.00B | 3.59B |
Stockholders Equity | 11.14B | 10.78B | 9.79B | 9.10B | 8.98B | 9.14B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 430.26M | 275.98M | 582.78M | -191.39M | -160.00M |
Operating Cash Flow | 0.00 | 1.42B | 903.73M | 1.09B | 563.74M | 805.00M |
Investing Cash Flow | 0.00 | -992.46M | -330.12M | -522.39M | -434.04M | -1.42B |
Financing Cash Flow | 0.00 | -727.59M | -273.27M | -328.59M | 885.92M | -220.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥4.41B | 8.16 | 3.48% | 0.23% | -14.50% | ||
71 Outperform | ¥4.34B | 7.33 | 4.89% | 7.71% | 44.35% | ||
68 Neutral | ¥4.05B | 16.40 | 3.41% | -11.75% | -52.23% | ||
66 Neutral | ¥3.84B | 8.48 | 4.54% | 3.82% | ― | ||
62 Neutral | $16.65B | 11.30 | -7.38% | 3.01% | 1.59% | -23.30% | |
57 Neutral | ¥4.79B | 11.74 | 4.35% | -1.72% | ― | ||
39 Underperform | ¥3.68B | ― | ― | 33.86% | 69.12% |